CD4 and sarcoidosis: It has also been reported that the proliferative capacity of CD4+ T cells in peripheral blood of patients with sarcoidosis was decreased, compared with healthy controls, and that proliferative capacity was restored to the level of healthy controls by blockade of the PD-1 pathway [12].